Status:
RECRUITING
A Usability Validation of the MuCopilot Mobile Application, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis
Lead Sponsor:
Ad scientiam
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study aims to assess the usability and safety of use of MuCopilot, a smartphone application that measures objective data on lung function, global exercise capacity and patient reported outcomes of...
Eligibility Criteria
Inclusion
- Aged ⩾ 18 years old
- Patients diagnosed with cystic fibrosis
- Enrolled in or benefiting of a Social Security program
- Having read the information sheet and signed the informed consent form
- Owning a personal smartphone which version is above 14 for IOS and 8 for Android included with a good internet connexion
- Able to read French and understand pictograms on a smartphone app
Exclusion
- History of lung transplantation
- Pregnant women and women who are breastfeeding
- Any medical condition that could interfere with the proper conduct and results of the study (clinician's judgement)
- Illiterate in French
- Inability to use a smartphone or MuCopilot application
- Person under legal protection (including guardianship or curatorship)
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT06132048
Start Date
July 1 2024
End Date
February 1 2025
Last Update
January 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CRCM Mixte - Hôpital Charles Nicolle
Rouen, France, 76031